Detalles de la búsqueda
1.
Evolutionary trajectories of small cell lung cancer under therapy.
Nature;
627(8005): 880-889, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38480884
2.
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.
Cell;
150(6): 1107-20, 2012 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-22980975
3.
[Trimodal Therapy for Stage IIIA-B NSCLC Involving High Dose Neoadjuvant Chemoradiotherapy. Is Surgery a Rational Option?] / Trimodale Therapie des NSCLC im Stadium IIIA-B mittels neoadjuvanter Hochdosisradiochemotherapie. Stellt die Operation eine sinnvolle Option dar?
Zentralbl Chir;
142(S 01): S26-S32, 2017 Sep.
Artículo
en Alemán
| MEDLINE | ID: mdl-28958107
4.
GILT--A randomised phase III study of oral vinorelbine and cisplatin with concomitant radiotherapy followed by either consolidation therapy with oral vinorelbine and cisplatin or best supportive care alone in stage III non-small cell lung cancer.
Strahlenther Onkol;
192(4): 216-22, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26809652
5.
Combined point mutation in KRAS or EGFR genes and EML4-ALK translocation in lung cancer patients.
Future Oncol;
10(4): 529-32, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24754584
6.
Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER Trial.
Hemasphere;
7(7): e917, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37427145
7.
Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer.
Mod Pathol;
25(11): 1473-80, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22684217
8.
Genomic Profiling Identifies Outcome-Relevant Mechanisms of Innate and Acquired Resistance to Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Lung Cancer.
JCO Precis Oncol;
32019.
Artículo
en Inglés
| MEDLINE | ID: mdl-32914023
9.
Stereotactic, high single-dose irradiation of stage I non-small cell lung cancer (NSCLC) using four-dimensional CT scans for treatment planning.
Lung Cancer;
60(2): 193-9, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18045732
10.
A randomized, controlled trial evaluating the efficacy and safety of BTH1677 in combination with bevacizumab, carboplatin, and paclitaxel in first-line treatment of advanced non-small cell lung cancer.
J Immunother Cancer;
6(1): 16, 2018 02 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-29486797
11.
Large cell neuroendocrine lung carcinoma induces peripheral T-cell repertoire alterations with predictive and prognostic significance.
Lung Cancer;
119: 48-55, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29656752
12.
Overcoming EGFRG724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors.
Nat Commun;
9(1): 4655, 2018 11 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30405134
13.
A phase II study of irinotecan (CPT-11) and carboplatin in patients with limited disease small cell lung cancer (SCLC).
Lung Cancer;
57(2): 181-6, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17442447
14.
65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-small-cell lung cancer.
Lung Cancer (Auckl);
8: 217-229, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29158696
15.
Molecular Pathology and Personalized Medicine: The Dawn of a New Era in Companion Diagnostics-Practical Considerations about Companion Diagnostics for Non-Small-Cell-Lung-Cancer.
J Pers Med;
6(1)2016 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26784235
16.
Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study).
J Thorac Oncol;
11(1): 85-93, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26762743
17.
Clinicopathological Characteristics of RET Rearranged Lung Cancer in European Patients.
J Thorac Oncol;
11(1): 122-7, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26762747
18.
Final results from a Phase II study of pemetrexed and cisplatin with concurrent thoracic radiation after Pem-Cis induction in patients with unresectable locally advanced non-squamous non-small cell lung cancer (NSCLC).
Lung Cancer;
88(2): 160-6, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25758556
19.
A randomized Phase 2 study of pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in patients with completely resected stage IB or II Non-Small-Cell Lung Cancer.
Lung Cancer;
90(3): 397-404, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26791798
20.
MET amplification status in therapy-naïve adeno- and squamous cell carcinomas of the lung.
Clin Cancer Res;
21(4): 907-15, 2015 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25492085